Cardiol Therapeutics Secures Record-breaking $13.5 Million in Common Shares Public Offering.
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares Cardiol Therapeutics, a leading biotechnology company specializing in heart disease treatments,